InvestorsHub Logo
icon url

Ecomike

07/25/18 12:21 PM

#1956 RE: PennyStockTrader2 #1955

My fishing nets are still deployed for more SGSI shares. Hard to understand why a stock like this gets so ignored while folks flock to dilution machines printing 10s of billions of shares to feed sheep?

That $300,000 grant they just scored and issued news on a day ago is 1/2 of the market cap at the bid.

That is just crazy undervalued. And they have revenue and sales and a product on Walmart store shelves already. In fact they had a $500,000 inventory of Venodol 6 months ago, and that went to consignment at Walmart, and did not yet show up as revenue and gross profit, was not listed as an asset on the last report.

Once again that $500,000 of Venodol at cost of $500,000, is 80% of today's market cap at .02/share with the float only about 5 mil shares as the two founders/directors/CEOs own about 80% of the OS shares.

This is a real biotech folks, most are valued at 100,000% more that STLT. Wake up peeps!! Smell the coffee!!
icon url

Ecomike

08/22/18 12:02 PM

#1959 RE: PennyStockTrader2 #1955

Good news, STLT 10-Q is out. Awesome Venodol gross profit margin, but the revenue is pathetic so far, even seems to be down. They need to find a way to ramp up sales. The product is awesome and could be a huge winner.

Insiders/CEO seem to be paying the bills with loans, K4. Convertible debt conversion so far seems to have been 25/30 cents and higher and not much volume. Still looks like a bargain.